Invention Grant
- Patent Title: Subcutaneous injection formulation for reducing body weight and uses thereof
-
Application No.: US16327466Application Date: 2017-08-25
-
Publication No.: US10716824B2Publication Date: 2020-07-21
- Inventor: Yu-Fang Ling
- Applicant: Caliway Biopharmaceuticals Co., Ltd.
- Applicant Address: TW New Taipei
- Assignee: Caliway Biopharmaceuticals Co., Ltd.
- Current Assignee: Caliway Biopharmaceuticals Co., Ltd.
- Current Assignee Address: TW New Taipei
- Agency: Polsinelli PC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6e399999 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@53898fe2
- International Application: PCT/IB2017/055129 WO 20170825
- International Announcement: WO2018/037384 WO 20180301
- Main IPC: A61K36/00
- IPC: A61K36/00 ; A61K36/9066 ; A61K8/34 ; A61K8/86 ; A61K8/11 ; A61Q19/06 ; A61P43/00 ; A61K9/00 ; A61K9/08 ; A61K9/107 ; A61K31/05 ; A61K31/12 ; A61K36/82 ; A61K45/06 ; A61K47/44 ; A61P3/04

Abstract:
The present invention provides a subcutaneous injection formulation for reducing body weight. The subcutaneous injection formulation for reducing body weight comprises drug-containing micelles made of a polyoxyethylene castor oil derivative or polyoxyethylene castor oil derivatives, and a curcuminoid or curcuminoids encapsulated in the drug-containing micelles. The subcutaneous injection formulation for reducing body weight can reduce body weight and visceral fat on overweight or obese subjects, and has the advantages of low dosage, high stability, high fat tissue bioavailability, few side effects, and sustained release.
Public/Granted literature
- US20190167753A1 A SUBCUTANEOUS INJECTION FORMULATION FOR REDUCING BODY WEIGHT AND USES THEREOF Public/Granted day:2019-06-06
Information query